Conclusions & Recommendations
TEC 26
26.2.2 - TEC recommendations to all countries implementing modified strategies
2022
Heading 2
Collect information on the feasibility and community acceptability of modified treatment strategies
Conclusion/Recommendation:
This recommendation has been shared by the Program Team with countries implementing modified treatment strategies. Few countries have conducted modified strategies, so information on feasibility and acceptability is not yet available. TT (5/8/2023): The action stated for 26.2.1 will serve the purpose for this recommendation.
alternative treatment strategies
TEC 26
26.2.1 - TEC recommendations to all countries implementing modified strategies
2022
Heading 2
Collect cost data to understand the additional cost of modified strategies implementing multiple rounds at different intervals and different population targets
Conclusion/Recommendation:
This recommendation has been shared by the Program Team with countries implementing modified treatment strategies. Few countries have conducted modified strategies, so cost data is not yet available. TT (5/8/2023): The national program of Ethiopia has developed a TOR and hired a consultant to follow up all interventions happening under the modified strategy and produce detailed report as per the recommendations of the TEC.
alternative treatment strategies, funding
TEC 26
26.1.8 - TEC recommendations to ITI management
2022
Heading 2
Follow up with Pfizer on any feedback they may have on the revised TEC Charter, then circulate the final revised Charter to TEC
Conclusion/Recommendation:
Ongoing.
recommendations for ITI management
TEC 26
26.1.7 - TEC recommendations to ITI management
2022
Heading 2
Continue discussions within TFGH about how best to engage with the antimicrobial resistance (AMR) community
Conclusion/Recommendation:
Ongoing. AMR is a priority development area for the new TFGH CEO.
recommendations for ITI management
TEC 26
26.1.6 - TEC recommendations to ITI management
2022
Heading 2
Follow up on the timing and plans for the billionth Zithromax® dose donated as an opportunity to celebrate this milestone and recognize the generosity of our donor
Conclusion/Recommendation:
ITI is working with Pfizer to celebrate and publicize this milestone in conjunction with World NTD Day in January 2023.
recommendations for ITI management
TEC 26
26.1.5 - TEC recommendations to ITI management
2022
Heading 2
Include more time on future agendas for application reviews by adding a day to TEC 27
Conclusion/Recommendation:
This recommendation was implemented at TEC 27.
TEC meeting management
TEC 26
26.1.4 - TEC recommendations to ITI management
2022
Heading 2
Outline on the maps the districts being requested so that they're easier to find
Conclusion/Recommendation:
ITI is working with its developer to implement this change before TEC 29.
TEC meeting management
TEC 26
26.1.3 - TEC recommendations to ITI management
2022
Heading 2
Use bigger font on supply chain slides and break out modified strategies as a separate color on the graphs so the additional drug for modified strategies can be visualized
Conclusion/Recommendation:
This recommendation was implemented at TEC 27.
TEC meeting management
TEC 26
26.1.2 - TEC recommendations to ITI management
2022
Heading 2
Include national program manager participation at future TEC meetings when applications being presented are non-routine and to hear feedback on their implementation of modified strategies
Conclusion/Recommendation:
This is noted for future meetings.
TEC meeting management, alternative treatment strategies
TEC 26
26.1.1 - TEC recommendations to ITI management
2022
Heading 2
Draft a manuscript for publication on the challenges facing national programs, authored by the 6 countries that presented applications at TEC 26
Conclusion/Recommendation:
This was put on hold; ITI leadership is now questioning its timeliness and relevance.
recommendations for ITI management, research, alternative treatment strategies